Literature DB >> 19052835

Necrotising scleritis and connective tissue disease--three cases and a review.

Sharmin Nizam1, Annette Johnstone, Michael Green, Andrew Gough.   

Abstract

Necrotising scleritis is a severe form of anterior scleritis which is known to be associated with connective tissue disease but has not previously been reported in association with limited scleroderma. It is often a difficult condition to treat and without adequate early intervention leads to significant morbidity including visual loss. We report three cases of necrotising scleritis, two occurring in the context of previously unreported associations and a third case to compare presentation of the condition and highlight difficulties in management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052835     DOI: 10.1007/s10067-008-1054-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.

Authors:  K Ahmadi-Simab; P Lamprecht; B Nölle; M Ai; W L Gross
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

Review 2.  Biologic therapies for inflammatory eye disease.

Authors:  Lyndell Lim; Eric B Suhler; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2006 May-Jun       Impact factor: 4.207

3.  Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.

Authors:  C M G Cheung; P I Murray; C O S Savage
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

Review 4.  MMF and eye disease.

Authors:  M Zierhut; N Stübiger; K Siepmann; C M E Deuter
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 5.  Scleral patch graft in the management of necrotizing scleritis.

Authors:  Q D Nguyen; C S Foster
Journal:  Int Ophthalmol Clin       Date:  1999

6.  Successful treatment of surgically induced necrotizing scleritis with tacrolimus.

Authors:  Alvin L Young; S M Wong; Alfred T S Leung; Gloria Y S Leung; Lulu L Cheng; Dennis S C Lam
Journal:  Clin Exp Ophthalmol       Date:  2005-02       Impact factor: 4.207

7.  Cyclosporin therapy for severe scleritis.

Authors:  D Wakefield; P McCluskey
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

8.  Low-dose methotrexate therapy for ocular inflammatory disease.

Authors:  S S Shah; C Y Lowder; M A Schmitt; W S Wilke; G S Kosmorsky; D M Meisler
Journal:  Ophthalmology       Date:  1992-09       Impact factor: 12.079

9.  Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

Authors:  C S Foster; S L Forstot; L A Wilson
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

10.  Intravenous pulse methylprednisolone in scleritis.

Authors:  P McCluskey; D Wakefield
Journal:  Arch Ophthalmol       Date:  1987-06
View more
  2 in total

Review 1.  Ocular manifestations of rheumatic diseases.

Authors:  Adam Kemeny-Beke; Peter Szodoray
Journal:  Int Ophthalmol       Date:  2019-10-03       Impact factor: 2.031

2.  Rare cause of red eye in scleroderma.

Authors:  Debashish Mishra; Shefali K Sharma
Journal:  BMJ Case Rep       Date:  2020-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.